A research team at the VIB-KU Leuven Center for Microbiology has developed a novel screening method to identify antimicrobial properties of volatile substances. With this assay, they tested the vapour-phase-mediated activity of 175 essential oils (EOs) and 37 EO components. Approximately half of them proved active against the most drug-resistant type of Candida. In a context of fungi showing increasing drug resistance, these findings may be useful in both medical and agricultural applications.
The research project, led by prof. Patrick Van Dijck, is rooted in the growing problem of antifungal drug resistance. Candida cells, for example, are quickly becoming tolerant to fluconazole, the most-used antifungal drug. Next to exploring experimental new techniques, scientists also seek to repurpose existing substances. Plant essential oils (EOs), metabolites obtained by steam distillation or cold citrus peel pressing, may offer interesting opportunities: they are made up of compounds that help protect the plant against microbial or herbivore attacks.
Identifying EOs and their compounds
In the VIB-KU Leuven Center for Microbiology, Adam Feyaerts gathered a collection of 175 different EOs, constituting a collection of over one thousand different small molecules. The aim was to identify biologically active compounds present in these complex mixtures. They therefore developed a new class of assay that allowed to identify new volatile substances with antifungal activities over a distance.
Prof. Patrick Van Dijck (VIB-KU Leuven): “We screened our whole collection of EOs for vapor-phase mediated antifungal activity against two human fungal pathogens, Candida albicans and Candida glabrata. Interestingly, we found that approximately half of the EOs and their compounds had vapour-phase-mediated activity against bothCandida species. Surprisingly, C. glabrata, the most drug-resistant species of the two was on average even more susceptible. In contrast, none of the currently used antifungals showed any vapour-phase-mediated activity.”
Numerous potential applications
This is now the first simple test to look for the vapor-phase-mediated antimicrobial activity of molecules. The same assay could also be used to test other biological activity. And although these findings still have to be confirmed in clinical trials, potential applications are numerous.
Co-author Adam Feyaerts (VIB-KU Leuven): “Our findings are for instance a starting point for the development of molecules that could also be used in vaporizers. After all, volatiles can access otherwise hard to reach areas. Think of possibilities such as maintaining hygiene in hospitals or treat patients with lung infections. There are agricultural options too, such as preventing post-harvest contamination or protecting crops against pests.”
Learn more: Plant-derived volatiles may serve as future antifungals
The Latest on: Antifungal drug resistance
[google_news title=”” keyword=”Antifungal drug resistance” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antifungal drug resistance
- Buy Rating Affirmed for Scynexis on Robust Financials and Promising Antifungal Pipelineon May 10, 2024 at 9:15 am
Analyst Jason McCarthy of Maxim Group maintained a Buy rating on SCYNEXIS (SCYX – Research Report), retaining the price target of $8.00.
- Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infectionson May 9, 2024 at 12:35 pm
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- Researchers review current evidence on Candida auris, an emerging multidrug-resistant yeaston May 6, 2024 at 9:56 am
On October 25, 2022, the World Health Organization (WHO) published a list of nineteen priority fungal pathogens that pose significant clinical threats to global citizens. C. auris, a multi-drug ...
- Exeter announces new £3.4 million global funding for solutions to antifungal drug resistanceon May 3, 2024 at 7:50 am
Considering this threat, increasing frequencies of antifungal drug resistance amongst fungi in the natural environment and in patients undergoing hospital treatment means even fewer drugs are ...
- Mitigation of Human-Pathogenic Fungi That Exhibit Resistance to Medical Agents: Can Clinical Antifungal Stewardship Help?on April 6, 2024 at 5:00 pm
Evidence for resistance is growing Several antifungal resistance mechanisms are now known, including: drug efflux, alterations in drug targets, changes in cell membrane and lipid composition ...
- Global alarm as drug-resistant fungal infections rise, deaths near 2 millionon March 20, 2024 at 10:29 am
Fungal infections, also known as skin fungi ... could have widespread impacts on healthcare systems. The rise of multi-drug resistant fungi like Candida auris and Trichophyton indotineae is ...
- The threat of fungal infections is growing. Why is it so hard to make new drugs?on February 11, 2024 at 3:06 am
In late 2022, the WHO published their first-ever list of fungal priority pathogens — 19 fungi the agency said pose a significant threat to human health. It includes the highly drug-resistant ...
- Fighting the rising tide of antifungal resistance: a global challengeon May 18, 2023 at 4:07 am
In recent decades the problem of antibiotic resistance has been a primary focus for many organizations, with less attention directed towards antifungal resistance. The tide is turning, however.
- First Cases of Drug-Resistant Ringworm Detected in U.S.on May 17, 2023 at 4:59 pm
Scientists studying the condition suspect that the fungus may have become drug-resistant due to the misuse and overuse of topical antifungal treatments and corticosteroids (anti-inflammatory ...
- NHS implements antifungal resistance teston September 11, 2020 at 3:11 am
Standard treatment is to give what are known as the triazole class of antifungal drugs. However, there has been a significant worldwide increase in resistance to these medicines. “Early and accurate ...
via Bing News